Patents-Review.com
ClassID:

170383 ⎘

G01N2333/4725 - CPC Classification

Classification description:

Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates; Assays involving proteins of known structure or function as defined in the subgroups; Details Mucins, e.g. human intestinal mucin

Recent Application in this class:
#1
20260109745
2026-04-23

Colon and Pancreas Cancer Peptidomimetics

 #2
20260104417
2026-04-16

USE OF URINARY PROTEIN BIOMARKERS TO DISTINGUISH BETWEEN NEOPLASTIC AND NON-NEOPLASTIC DISEASE OF THE PROSTATE

 #3
20260072033
2026-03-12

USE OF EXTRACELLULAR VESICLES AND MICRONUCLEI OF CIRCULATING STROMAL CELLS AS PAN-CANCER BIOMARKERS FOR PREDICTING CLINICAL OUTCOMES

 #4
20260071178
2026-03-12

ADULT STEM CELL COMPOSITIONS AND METHODS OF IDENTIFICATION AND ISOLATION

 #5
20260029316
2026-01-29

METHOD FOR PRETREATMENT OF SPECIMEN FOR IMMUNOCHROMATOGRAPHIC TEST

 #6
20260002943
2026-01-01

BIOMARKERS FOR DIAGNOSING EQUINE ASTHMA

 #7
20250298012
2025-09-25

METHODS AND KITS FOR QUANTIFYING GLYCOSYLATED ANALYTES

 #8
20250297030
2025-09-25

ANTI-MUC17 NANOBODY AND USE THEREOF

 #9
20250263793
2025-08-21

METHODS OF DETECTING AND TREATING GYNECOLOGICAL DISEASES

 #10
20250237655
2025-07-24

BIOMARKERS FOR OVARIAN CANCER

 #11
20250129180
2025-04-24

NOVEL ANTI-MUC1 ANTIBODY AND USE THEREOF

 #12
20250110120
2025-04-03

METHOD FOR DETERMINATION OF MUTATED FORM OF MUCIN-1 PROTEIN IN A BIOLOGICAL SAMPLE

 #13
20250075278
2025-03-06

EPIGENTIC REGULATION AND CO-TARGETING APPROACHES OF PSMA IN PROSTRATE CANCER

 #14
20250075001
2025-03-06

ANTI-GLYCO-MUC1 ANTIBODIES AND THEIR USES

 #15
20250067732
2025-02-27

CRITICALLY-LOCKED MECHANICAL METAMATERIAL FOR HYPER-RESPONSIVE MOLECULAR PROFILING

 #16
20240426841
2024-12-26

KIT OF KL-6 PROTEIN ON EXOSOMES FOR AUXILIARY DIAGNOSIS OF INTERSTITIAL LUNG DISEASE AND USE THEREOF

 #17
20240418733
2024-12-19

METHOD FOR DETECTING KIDNEY DYSFUNCTION DIAGNOSTIC MARKER, METHOD FOR DETERMINING RENAL PROGNOSIS, DETECTION KIT FOR KIDNEY DYSFUNCTION DIAGNOSTIC MARKER, AND KIDNEY DYSFUNCTION DIAGNOSTIC MARKER

 #18
20240409622
2024-12-12

OPTIMIZED CROSSLINKERS FOR TRAPPING A TARGET ON A SUBSTRATE

 #19
20240385195
2024-11-21

PEPTIDE FOR DETECTING CA125 AND USE THEREOF

 #20
20240151726
2024-05-09

DIAGNOSTIC METHODS FOR LIVER DISORDERS

 #21
20240092900
2024-03-21

MARKERS OF ACUTE MYELOID LEUKEMIA STEM CELLS

 #22
20230408522
2023-12-21

MULTI-PROTEIN CLASSIFIER FOR DETECTING EARLY-STAGE OVARIAN CANCER

 #23
20230358750
2023-11-09

PROGNOSTIC VALUE OF BIOMARKERS IN PATIENTS WITH NON-SMALL CELL LUNG CANCER HAVING STABLE DISEASE

 #24
20230313307
2023-10-05

METHODS AND COMPOSITIONS FOR RISK PREDICTION, DIAGNOSIS, PROGNOSIS, AND TREATMENT OF PULMONARY DISORDERS

 #25
20230265384
2023-08-24

Adult stem cell compositions and methods of identification and isolation

 #26
20230203124
2023-06-29

METHODS OF ISOLATING T CELL RECEPTORS HAVING ANTIGENIC SPECIFICITY FOR A CANCER-SPECIFIC MUTATION

 #27
20230129844
2023-04-27

DIAGNOSTIC ANTIBODIES AGAINST MUCIN 17 AND USES THEREOF

 #28
20220372116
2022-11-24

Optimized crosslinkers for trapping a target on a substrate

 #29
20220291239
2022-09-15

METHODS FOR DETERMINING THE SEVERITY AND PROGNOSIS OF RSV INFECTION

 #30
20220291233
2022-09-15

MUCIN ISOFORMS IN DISEASES CHARACTERIZED BY BARRIER DYSFUNCTION

 #31
20220235143
2022-07-28

HUMANIZED ANTIBODIES TO MUCIN-16 AND METHODS OF USE THEREOF

 #32
20220089772
2022-03-24

Anti-glyco-MUC1 antibodies and their uses

 #33
20220003777
2022-01-06

Methods Employing Mucin-Specific Proteases

 #34
20220003770
2022-01-06

Classification and Treatment of Gastric Cancer

 #35
20210395321
2021-12-23

Colon and Pancreas Cancer Peptidomimetics

 #36
20210389312
2021-12-16

Method for detecting target substance, reagent for detecting target substance

 #37
20210364522
2021-11-25

METHODS FOR CAPTURING, ISOLATION, AND TARGETING OF CIRCULATING TUMOR CELLS AND DIAGNOSTIC AND THERAPEUTIC APPLICATIONS THEREOF

 #38
20210223267
2021-07-22

METHODS AND DEVICES FOR DETECTING DIABETIC NEPHROPATHY AND ASSOCIATED DISORDERS

 #39
20210198738
2021-07-01

Methods and compositions for risk prediction, diagnosis, prognosis, and treatment of pulmonary disorders

 #40
20210024618
2021-01-28

OPTIMIZED CROSSLINKERS FOR TRAPPING A TARGET ON A SUBSTRATE

 #41
20200392458
2020-12-17

MODIFIED NATURAL KILLER CELLS AND NATURAL KILLER CELL LINES TARGETTING TUMOUR CELLS

 #42
20200369782
2020-11-26

Monoclonal Antibodies, Compositions and Methods for Detecting Mucin-like Protein (MLP) as a Biomarker for Ovarian and Pancreatic Cancer

 #43
20200369729
2020-11-26

Peptidomimetics, method of synthesis and uses thereof

 #44
20200340996
2020-10-29

Methods for detecting and for treating pancreatic cancer

 #45
20200261603
2020-08-20

Anti-human MUC1 antibody Fab fragment

 #46
20200191802
2020-06-18

Methods for diagnosing or predicting chronic bronchitis

 #47
20200171174
2020-06-04

NOVEL ANTI-HUMAN MUC1 ANTIBODY FAB FRAGMENT

 #48
20200165310
2020-05-28

Colon and pancreas cancer peptidomimetics

 #49
20200062842
2020-02-27

ANTIBODIES DIRECTED AGAINST SIGNAL PEPTIDES, METHODS AND USES THEREOF

 #50
20200057070
2020-02-20

DIAGNOSTIC METHODS FOR LIVER DISORDERS

 #51
20190310257
2019-10-10

METHOD FOR DISCRIMINATING BETWEEN PROSTATE CANCER AND A BENIGN PROSTATE DISEASE

 #52
20190307906
2019-10-10

Anti-human MUC1 antibody Fab fragment

 #53
20190302028
2019-10-03

Method for Measuring Tear Constituents in a Tear Sample

 #54
20190276514
2019-09-12

Therapeutic and diagnostic cloned MHC-unrestricted receptor specific for the MUC1 tumor associated antigen

 #55
20190233893
2019-08-01

Methods of diagnosing endometriosis

 #56
20190211099
2019-07-11

METHODS AND COMPOSITIONS FOR TREATING CANCER WITH SIGLEC-9 ACTIVITY MODULATORS

 #57
20190185558
2019-06-20

ANTIBODIES DIRECTED AGAINST SIGNAL PEPTIDES, METHODS AND USES THEREOF

 #58
20190145980
2019-05-16

Methods for capturing, isolation, and targeting of circulating tumor cells and diagnostic and therapeutic applications thereof

 #59
20190119632
2019-04-25

Adult stem cell compositions and methods of identification and isolation

 #60
20190119400
2019-04-25

Anti-glyco-MUC1 antibodies and their uses

 #61
20190049453
2019-02-14

Classification and Treatment of Gastric Cancer

 #62
20190049450
2019-02-14

Method for Assessing and Predicting Efficacy of Breast Cancer Treatment with a Long-Acting Topoisomerase I Inhibitor

 #63
20190040467
2019-02-07

Methods and compositions for risk prediction, diagnosis, prognosis, and treatment of pulmonary disorders

 #64
20180258160
2018-09-13

Optimized crosslinkers for trapping a target on a substrate

 #65
20180120323
2018-05-03

Detection of ovarian cancer using antibody arrays

 #66
20180074075
2018-03-15

Biomarker for barrett's oesophagus

 #67
20180067049
2018-03-08

Plasmonic nanoparticle immunoassay method

 #68
20180024133
2018-01-25

Method of detecting the level of a glycan

 #69
20170370947
2017-12-28

Methods and Devices for Detecting Diabetic Nephropathy and Associated Disorders

 #70
20170362288
2017-12-21

Colon and pancreas cancer peptidomimetics

 #71
20170355777
2017-12-14

Monoclonal antibodies, compositions and methods for detecting mucin-like protein (MLP) as a biomarker for ovarian and pancreatic cancer

 #72
20170319655
2017-11-09

MUC1 decoy peptides for treatment and prevention of bacterial infections

 #73
20170292956
2017-10-12

Markers for detection of gastric cancer

 #74
20170254816
2017-09-07

METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE

 #75
20170242023
2017-08-24

Methods Of Detecting Ectopic Pregnancy

 #76
20170218042
2017-08-03

METHODS OF ISOLATING T CELL RECEPTORS HAVING ANTIGENIC SPECIFICITY FOR A CANCER-SPECIFIC MUTATION

 #77
20170146537
2017-05-25

Agents and methods for determining colorectal cancer status

 #78
20170122951
2017-05-04

Molecular analysis of tumor samples

 #79
20170089906
2017-03-30

BIOMARKERS FOR OVARIAN CANCER

 #80
20170038388
2017-02-09

Diagnostic methods for liver disorders

 #81
20170022264
2017-01-26

THERAPEUTIC AND DIAGNOSTIC CLONED MHC-UNRESTRICTED RECEPTOR SPECIFIC FOR THE MUC1 TUMOR ASSOCIATED ANTIGEN

 #82
20170001197
2017-01-05

Non-invasive monitoring cancer using integrated microfluidic profiling of circulating microvesicles

 #83
20160327477
2016-11-10

Method for diagnosing lung diseases

 #84
20160313337
2016-10-27

Method for discriminating between prostate cancer and a benign prostate disease

 #85
20160311922
2016-10-27

GLYCAN-INTERACTING COMPOUNDS

 #86
20160305960
2016-10-20

Methods for discriminating between prostate cancer and a benign prostate-disease

 #87
20160266148
2016-09-15

Salivary biomarkers for monitoring of type 2 diabetes treatment

 #88
20160245817
2016-08-25

MUCIN 5B AS A PANCREATIC CYST FLUID SPECIFIC BIOMARKER FOR ACCURATE DIAGNOSIS OF MUCINOUS CYSTS AND OTHER MARKERS USEFUL FOR DETECTION OF PANCREATIC MALIGNANCY

 #89
20160216267
2016-07-28

Detection of ovarian cancer using antibody arrays

 #90
20160209415
2016-07-21

METHOD TO PREDICT OR DIAGNOSE A COLORECTAL CANCER

 #91
20160109455
2016-04-21

COMPOSITIONS FOR OVARIAN CANCER ASSESSMENT HAVING IMPROVED SPECIFICTY

 #92
20160090413
2016-03-31

ANTI-MUCIN ANTIBODIES FOR EARLY DETECTION AND TREATMENT OF PANCREATIC CANCER

 #93
20160069885
2016-03-10

Detection of early-stage pancreatic adenocarcinoma

 #94
20160032392
2016-02-04

METHODS OF DIAGNOSING ENDOMETRIOSIS

 #95
20150359868
2015-12-17

Method of Treating Patients with a Mucinous Glycoprotein (MUC-1) Vaccine

 #96
20150337023
2015-11-26

Colon and pancreas cancer peptidomimetics

 #97
20150315289
2015-11-05

Antibodies reactive with an epitope located in the N-terminal region of MUC5AC comprising cysteine-rich subdomain 2 (Cys2)

 #98
20150309032
2015-10-29

Method for assessing and predicting efficacy of breast cancer treatment with a long-acting topoisomerase I inhibitor

 #99
20150276765
2015-10-01

Methods and Devices for Detecting Diabetic Nephropathy and Associated Disorders

 #100
20150168412
2015-06-18

Methods And Marker Combinations For Screening For Predisposition To Lung Cancer

 #101
20150165076
2015-06-18

Anti-mucin antibodies for early detection and treatment of pancreatic cancer

 #102
20150004622
2015-01-01

Biomarker for Barrett's Oesophagus

 #103
20140348762
2014-11-27

Diagnostic methods

 #104
20140220028
2014-08-07

Antibodies directed against signal peptides, methods and uses thereof

 #105
20140199242
2014-07-17

Compositions and methods for detection and treatment of cancer

 #106
20140011217
2014-01-09

Detection of targets using magnetic resonance

 #107
20130247232
2013-09-19

Colon and pancreas cancer peptidomimetics

 #108
20130045490
2013-02-21

Antibody against mucin 1 (MUC1) protein and use of same

 #109
20130022593
2013-01-24

METHODS OF DIAGNOSING ENDOMETRIOSIS

 #110
20130005598
2013-01-03

Methods for Diagnosing The Malignant Potential of Pancreatic Cystic Lesions

 #111
20120288873
2012-11-15

Biomarkers for the detection and screening of down syndrome

 #112
20120214174
2012-08-23

GENE AND POLYPEPTIDE RELATING TO BREAST CANCER

 #113
20120195883
2012-08-02

Monocot seed product comprising a human blood protein

 #114
20120142903
2012-06-07

Methods For Detecting And Analyzing N-Glycolylneuraminic Acid (NEU5GC) In Biological Materials

 #115
20120141375
2012-06-07

Anti-mucin antibodies for early detection and treatment of pancreatic cancer

 #116
20120135881
2012-05-31

Markers for detection of gastric cancer

 #117
20120100560
2012-04-26

DEVICE FOR CAPTURE, ENUMERATION, AND PROFILING OF CIRCULATING TUMOR CELLS

 #118
20120071704
2012-03-22

MITOCHONDRIAL LOCALIZATION OF MUC1

 #119
20120071334
2012-03-22

Methods And Marker Combinations For Screening For Predisposition To Lung Cancer

 #120
20120058916
2012-03-08

DIAGNOSTIC METHODS FOR LIVER DISORDERS

 #121
20120040476
2012-02-16

Immunoassay reagent for KL-6 assay

 #122
20120021444
2012-01-26

METHOD FOR DIAGNOSIS OF CYSTIC FIBROSIS USING KL-6 LEVELS

 #123
20120009597
2012-01-12

Biomarker for Barrett's Oesophagus

 #124
20110287556
2011-11-24

Blood group antigens of different types for diagnostic and therapeutic applications

 #125
20110281277
2011-11-17

COMPOSITION, KIT, AND METHOD FOR DIAGNOSING COLORECTAL CANCER OR OVARIAN CANCER

 #126
20110256539
2011-10-20

Methods for Detecting Tumor Origin Based on MUC1, MUC2, and CK-17 Expression Levels

 #127
20110251246
2011-10-13

Small molecule inhibitors of MUC1 and methods of identifying the same

 #128
20110217315
2011-09-08

Methods and compositions for risk prediction, diagnosis, prognosis, and treatment of pulmonary disorders

 #129
20110207656
2011-08-25

MUC1, caspase-8, and DED-containing proteins

 #130
20110201036
2011-08-18

Endometriosis markers

 #131
20110177959
2011-07-21

Methods and Devices for Detecting Kidney Transplant Rejection

 #132
20110171631
2011-07-14

Methods of diagnosing endometriosis

 #133
20110165072
2011-07-07

Detection of early-stage pancreatic adenocarcinoma

 #134
20110065608
2011-03-17

Devices for Detecting Renal Disorders

 #135
20110065599
2011-03-17

Methods and Devices for Detecting Kidney Damage

 #136
20110065598
2011-03-17

Methods and Devices for Detecting Diabetic Nephropathy and Associated Disorders

 #137
20110065593
2011-03-17

Computer Methods and Devices for Detecting Kidney Damage

 #138
20110065137
2011-03-17

Methods and devices for detecting obstructive uropathy and associated disorders

 #139
20110065136
2011-03-17

Methods and Devices for Detecting Glomerulonephritis and Associated Disorders

 #140
20100240872
2010-09-23

Anti-Muc 17 antibody

 #141
20100221770
2010-09-02

Methods for detecting and analyzing N-glycolylneuraminic acid (Neu5Gc) in biological materials

 #142
20100183589
2010-07-22

Monocot seed product comprising a human serum albumin protein

 #143
20100136017
2010-06-03

Diagnostic tumor markers, drug screening for tumorigenesis inhibition, and compositions and methods for treatment of cancer

 #144
20100119691
2010-05-13

EXPRESSION OF HUMAN MILK PROTEINS IN TRANSGENIC PLANTS

 #145
20100105067
2010-04-29

Biomarkers for ovarian cancer

 #146
20100098683
2010-04-22

MUC1 and galectin-3

 #147
20100093000
2010-04-15

Tyrosine phosphorylation sites

 #148
20100031394
2010-02-04

Human Blood Proteins Expressed in Monocot Seeds

 #149
20090286854
2009-11-19

Aptamers directed to MUC1

 #150
20090258004
2009-10-15

HUMAN BLOOD PROTEINS EXPRESSED IN MONOCOT SEEDS

 #151
20090215091
2009-08-27

Diagnostic panel of cancer antibodies and methods for use

 #152
20090136520
2009-05-28

Mitochondrial localization of MUC1

 #153
20090098054
2009-04-16

Methods and compositions relating to promoter regulation by MUC1 and KLF proteins

 #154
20090092603
2009-04-09

EARLY DIAGNOSIS AND TREATMENT OF DRUG RESISTANCE IN MUC1-POSITIVE CANCER

 #155
20090092600
2009-04-09

Methods and compositions relating to the regulation of MUC1 by HSF1 and STAT3

 #156
20090081685
2009-03-26

METHODS AND COMPOSITIONS FOR THE DETECTION OF OVARIAN DISEASE

 #157
20090081172
2009-03-26

THERAPEUTIC AND DIAGNOSTIC CLONED MHC-UNRESTRICTED RECEPTOR SPECIFIC FOR THE MUC1 TUMOR ASSOCIATED ANTIGEN

 #158
20080318277
2008-12-25

Expression of human milk proteins in transgenic plants

 #159
20080318237
2008-12-25

Methods of diagnosing endometriosis

 #160
20080160546
2008-07-03

Methods and marker combinations for screening for predisposition to lung cancer

 #161
20080107661
2008-05-08

MUC1 and ABL

 #162
20080050503
2008-02-28

Expression of human milk proteins in transgenic plants

 #163
20070275409
2007-11-29

Methods for detecting and analyzing N-glycolylneuraminic acid (Neu5Gc) in biological materials

 #164
20070224652
2007-09-27

Blood group antigens of different types for diagnostic and therapeutic applications

 #165
20070172901
2007-07-26

Method for the evaluation of the functional status of the growth factor receptor protein expressed in malignant tumors

 #166
20070160526
2007-07-12

Detection, monitoring and treatment of cancer

 #167
20070105161
2007-05-10

Methods of identifying compounds that inhibit Notch cleavage

 #168
20070014844
2007-01-18

Method of treating patients with a mucinous glycoprotein (MUC-1) vaccine

 #169
20070003985
2007-01-04

Specific mucin expression as a marker for pancreatic cancer

 #170
20060263334
2006-11-23

Therapeutic and diagnostic cloned MHC-unrestricted receptor specific for the MUC1 tumor associated antigen

 #171
20060150262
2006-07-06

Novel mucin-like polypeptides

 #172
20060029956
2006-02-09

Methods and compositions for the detection of ovarian disease

 #173
20060018895
2006-01-26

Murine monoclonal anti-idiotype antibody 11D10 and methods of use thereof

 #174
20050214300
2005-09-29

Methods for treating cancer using Porimin as a target